Together, these findings corroborate our hypothesis that in SCD, the systemic actions of PNP and ADA are increased, which eventually results in accelerated purine nucleoside metabolism with subsequent depletion of tissue‐protective purines and simultaneous accumulation of tissue‐damaging purines. The gene discussed is ADA; the disease is Schnyder corneal dystrophy.